May 9, 2013 11:10 AM | 1 min read |
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
In a report published Thursday, Benchmark Company analyst James Terwilliger downgraded the rating on ICU Medical (NASDAQ: ICUI) from Buy to Hold, but reiterated the $69.00 price target.In the report, Terwilliger noted, “We are lowering our recommendation to Hold from Buy based on valuation as ICU Medical has traded close to our $69.00 price target. Our $69.00 price target represents 20 times our 2013 EPS estimate of $2.80 plus $13.00 in cash per share. We remind investors that ICU Medical has a strong balance sheet with approximately $16.00 in cash per share and no long-term debt. We believe that ICU Medical could be exploring a sale of the company, according to a Bloomberg News report.”ICU Medical closed on Wednesday at $68.80.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.